Availability of Contact Information Helps Individuals amid Coronavirus Outbreak

Health screenings and check-ups for new babies are still relevant during the coronavirus outbreak. These check-ups help families to make informed decisions about how to protect their infants. Hence, stakeholders in the newborn screening market are increasing awareness about additional precautions that need to be taken such as in cases of follow-up testing after the screening results are received.

Since healthcare is one of the essential industries worldwide, state and territorial newborn screening programs are being carried out even during the COVID-19 situation. Healthcare providers in the newborn screening market are capitalizing on this opportunity to offer comprehensive services in blood spot screening, hearing, and critical congenital heart disease (CCHD) test. Clinicians in the U.S. are increasing the availability of contact information and listing it on official state pages to keep individuals abreast with all updates.

newborn screening market segmentation

Request a sample to get extensive insights into the Newborn Screening Market 

Lack of Data for New Pediatric Health States Increases Costs for Clinicians

The newborn screening market is projected to reach the valuation of US$ 3.3 Bn by 2031. This is evident since the number of conditions assessable by newborn screening methods is increasing, resulting in additional cost for the healthcare system. Moreover, lack of data on long-term consequences of new conditions and scarce follow-up information for screened conditions are hampering the decision making process of healthcare providers. Hence, there is a need to standardize valuation techniques for pediatric health states in the newborn screening market.

There is a need to clarify methodological strengths and flaws in cost effectiveness and cost utility analysis of new pediatric health states.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Medical Outcomes Increase with Connectivity Between Screening Programs and Healthcare Providers

Companies in the newborn screening market are focusing on reducing the morbidity and mortality associated with heritable disorders in newborns and children. Altarum - a non-profit research and consulting organization has been selected by the Health Resources and Services Administration (HRSA) to lead the Innovations in Newborn Screening Interoperability Resource Center. Such initiatives explain why the newborn screening market is expected to advance at a robust CAGR of ~11% during the forecast period.

In order to improve medical outcomes of newborns and children, healthcare providers are taking efforts to enhance the connectivity between state public health newborn screening programs and healthcare providers. This is being achieved with the help of information management and technical assistance for newborn screening programs.

Evaluation of Screening Methods Helps in Policy Recommendations for New Treatments

Healthcare providers in the newborn screening market are setting their collaboration wheels in motion to assess the current state of pediatric screening. Rare disease-focused organizations such as the EveryLife Foundation for Rare Diseases, Retrophin, Inc., BioMarin Pharmaceutical Inc., Orchard Therapeutics Inc., and Sarepta Therapeutics have joined forces to evaluate the capacity of newborn screening in the U.S. Timely diagnosis to all newborns who may benefit from new treatments requires careful evaluation from healthcare organizations.

The evaluation by organizations in the newborn screening market will ensure policy recommendations that enable equitable access to newborn screening for all babies in the U.S.

Point-of-care Sickle Cell Screening Tools Reduce Mortality in Africa

Companies in the newborn screening market are expanding their revenue streams for babies with rare diseases. The European Commission is gaining recognition for shortening the path to rare disease diagnosis by increasing funding and tender opportunities for newborn screening and digital technologies. This is evident since thousands of distinct rare diseases are affecting a significant amount of newborns in Europe.

Moreover, Nigeria is gaining popularity for introducing its $2 10-minute rapid point-of-care tool, which has the potential to transform sickle cell screening for newborns. Thus, healthcare providers are unlocking growth opportunities in Africa to reduce child mortality with the help of innovations in sickle cell screening. The integration of newborn screening into existing primary healthcare immunization programs is being achieved within limited resources in Africa.

newborn screening market infographic

Stuck in a neck-to-neck competition with other brands? Request a custom report on Newborn Screening Market 

Analysts’ Viewpoint

The safe follow-up on newborn screening results has become a priority for healthcare providers and individuals during the COVID-19 outbreak. Rapid point-of-care tools are replacing conventional screening methods of collecting blood samples on a filter paper in cases of newborns suffering from sickle cell anemia. Despite many achievements, significant delays between the screening and the availability of the treatment are inhibiting growth of the newborn screening market. Hence, healthcare organizations should collaborate on R&D to make advancements in diagnostic medical technologies to reduce morbidity and mortality rate of newborns. Efforts should be made to increase the connectivity between state public health newborn screening programs and healthcare providers.

Newborn Screening Market: Overview

  • Newborn screening entails the screening of newborns in the first days of their lives for inborn errors of metabolism and certain disorders that can hinder their normal development
  • These disorders are not apparent at the time of baby's birth, but have the potential to cause permanent neurological, cognitive, tactile, and physical damage to the child. Early detection of such diseases enables initiation of suitable intervention to prevent permanent health issues for the child.
  • Different types of tests are used in the diagnosis of newborn disorders, including dry blood spot test, hearing screen test, critical congenital heart disease (CCHD) test, X ray or CT scan, and electrocardiogram (ECG)
  • The global newborn screening market has been expanding significantly due to the rise in prevalence of critical congenital heart defects and improved & precise diagnosis of NICU diseases

Newborn Screening Market: Drivers

  • Rise in prevalence and incidence of critical congenital heart defects, such as pulmonary atresia and tricuspid atresia are driving the demand for newborn screening. According to Centers for Disease Control and Prevention (CDC), an estimated 1% or about 40,000 births are affected by congenital heart defects each year in the U.S. alone. About one in four babies with CHD suffers from critical CHD. Infants with critical CHDs generally need surgery or other procedures in their first year of life.
  • Market players in the newborn screening are introducing new and advanced products based on upgraded techniques. This has enabled improved and precise diagnosis of infants suffering from critical congenital heart diseases. Advancements in point of care diagnostic devices and rise in emphasis on early diagnosis are likely to boost the global newborn screening market during the forecast period.

Newborn Screening Market: Segmentation

  • In terms of product, the global newborn screening market has been bifurcated into instruments and assay kits. The instruments segment has been split into tabletop and point-of-care testing. The instruments segment is anticipated to dominate the global newborn screening market during the forecast period.
  • Based on test type, the global newborn screening market has been classified into dry blood spot test, hearing screen test, critical congenital heart disease (CCHD) test, X-ray or CT scan, electrocardiogram (ECG) test, and others
  • Based on end user, the global newborn screening market has been segregated into hospitals, diagnostic centers, maternity & specialty clinics, and others. The hospitals segment dominated the global newborn screening market in terms of revenue in 2019.
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The global newborn screening report provides current and expected revenue (US$ Mn) for each of these segments from 2017 to 2031, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and the market from 2021 to 2031, along with market size estimations.

Newborn Screening Market: Regional Overview

  • In terms of region, the global newborn screening market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. These regions have been divided into major countries and sub-regions.
  • The current and expected revenue (US$ Mn) of the newborn screening market in these regions and their major countries have been provided in the report from 2017 to 2031, with CAGRs from 2021 to 2031
  • The study also offers a list of recommendations, highlights, and useful insights of the global newborn screening market, which would help new companies willing to enter the global newborn screening market and existing companies to increase their market share and in the decision-making process

Newborn Screening Market: Major Players

  • The newborn screening market report concludes with the company profiles section, which includes key information about major players in the global newborn screening market
  • Leading players analyzed in the global newborn screening market report include
    • PerkinElmer, Inc.
    • Trivitron Healthcare
    • Natus Medical Incorporated
    • Medtronic Plc
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • GE Healthcare (General Electric Company)
    • ZenTech S.A.
    • MP BIOMEDICALS
    • Baebies, Inc.
    • Masimo
  •  Each of these players has been profiled in the newborn screening market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Newborn Screening Market – Scope of the Report

TMR’s report on the global newborn screening market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2021 to 2031. The report provides revenue of the global newborn screening market for the period 2017–2031, considering 2019 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global newborn screening market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the newborn screening market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global newborn screening market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global newborn screening market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global newborn screening market.

The report delves into the competition landscape of the global newborn screening market. Key players operating in the global newborn screening market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global newborn screening market profiled in this report.

Key Questions Answered in Newborn Screening Market Report

  • What is the sales/revenue generated by newborn screening across all regions during the forecast period?
  • What are the opportunities in the global newborn screening market?
  • What are major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which product segment is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What is the market position of different companies operating in the global market?

Newborn Screening Market – Research Objectives and Research Approach

The comprehensive report on the global newborn screening market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global newborn screening market in terms of product, test type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global newborn screening market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Newborn Screening Market – Segmentation

TMR’s study on the global newborn screening market includes information divided into four segments: product, test type, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global newborn screening market are discussed in detail.

Product
  • Instruments
    • Tabletop
    • Point-of-care Testing
  • Assay Kits
Test Type
  • Dry Blood Spot Test
  • Hearing Screen Test
  • Critical Congenital Heart Disease (CCHD) Test
  • X-ray or CT Scan
  • Electrocardiogram (ECG) Test
  • Others
End User
  • Hospitals
  • Diagnostic Centers
  • Maternity & Specialty Clinics
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Report Scope and Market Segmentation 

    1.2. Research Highlights

2. Assumptions and Research Methodology 

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

    4.3. Global Newborn Screening Market Forecast

    4.4. Global Newborn Screening Market Outlook

5. Market Outlook

    5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

    5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    5.3. Overview of the Neonatal Research Funding/Grants

6. Global Newborn Screening Market Analysis, by Product

    6.1. Introduction 

    6.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Product

    6.3. Global Newborn Screening Market Forecast, by Product

        6.3.1. Instruments 

            6.3.1.1. Tabletop

            6.3.1.2. Point-of-Care Testing 

        6.3.2. Assay Kits

    6.4. Global Newborn Screening Market Analysis, by Product

7. Global Newborn Screening Market Analysis, by Test Type

    7.1. Introduction 

    7.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type

    7.3. Global Newborn Screening Market Forecast, by Test Type

        7.3.1. Dry Blood Spot Test

        7.3.2. Hearing Screen Test

        7.3.3. Critical Congenital Heart Disease (CCHD) Test

        7.3.4. X-ray or CT Scan

        7.3.5. Electrocardiogram (ECG) Test

        7.3.6. Others

    7.4. Global Newborn Screening Market Analysis, by Test Type

8. Global Newborn Screening Market Analysis, by End-user

    8.1. Introduction 

    8.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by End-user

    8.3. Global Newborn Screening Market Forecast, by End-user

        8.3.1. Hospitals

        8.3.2. Diagnostic Centers

        8.3.3. Maternity & Specialty Clinics

        8.3.4. Others

    8.4. Global Newborn Screening Market Analysis, by End-user

9. Global Newborn Screening Market Analysis, by Region

    9.1. Global Newborn Screening Market Scenario, by Region/Country

    9.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Region

    9.3. Global Newborn Screening Market Forecast, by Region

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

10. North America Newborn Screening Market Analysis

    10.1. North America Newborn Screening Market Overview

    10.2. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Country

    10.3. North America Newborn Screening Market Forecast, by Country

        10.3.1. U.S.

        10.3.2. Canada

    10.4. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Product

    10.5. North America Newborn Screening Market Forecast, by Product

        10.5.1. Instruments 

            10.5.1.1. Tabletop

            10.5.1.2. Point-of-Care Testing 

        10.5.2. Assay Kits

    10.6. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type

    10.7. North America Newborn Screening Market Forecast, by Test Type

        10.7.1. Dry Blood Spot Test

        10.7.2. Hearing Screen Test

        10.7.3. Critical Congenital Heart Disease (CCHD) Test

        10.7.4. X-ray or CT Scan

        10.7.5. Electrocardiogram (ECG) Test

        10.7.6. Others

    10.8. North America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user

    10.9. North America Newborn Screening Market Forecast, by End-user

        10.9.1. Hospitals

        10.9.2. Diagnostic Centers

        10.9.3. Maternity & Specialty Clinics

        10.9.4. Others

11. Europe Newborn Screening Market Analysis

    11.1. Europe Newborn Screening Market Overview

    11.2. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region

    11.3. Europe Newborn Screening Market Forecast, by Country/Sub-region

        11.3.1. Germany

        11.3.2. France

        11.3.3. U.K.

        11.3.4. Italy

        11.3.5. Spain

        11.3.6. Rest of Europe

    11.4. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Product

    11.5. Europe Newborn Screening Market Forecast, by Product

        11.5.1. Instruments 

            11.5.1.1. Tabletop

            11.5.1.2. Point-of-Care Testing 

        11.5.2. Assay Kits

    11.6. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type

    11.7. Europe Newborn Screening Market Forecast, by Test Type

        11.7.1. Dry Blood Spot Test

        11.7.2. Hearing Screen Test

        11.7.3. Critical Congenital Heart Disease (CCHD) Test

        11.7.4. X-ray or CT Scan

        11.7.5. Electrocardiogram (ECG) Test

        11.7.6. Others

    11.8. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by End-user

    11.9. Europe Newborn Screening Market Forecast, by End-user

        11.9.1. Hospitals

        11.9.2. Diagnostic Centers

        11.9.3. Maternity & Specialty Clinics

        11.9.4. Others

12. Asia Pacific Newborn Screening Market Analysis

    12.1. Asia Pacific Newborn Screening Market Overview

    12.2. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Asia Pacific Newborn Screening Market Forecast, by Country/Sub-region

        12.3.1. Japan

        12.3.2. China

        12.3.3. India

        12.3.4. South Korea

        12.3.5. Rest of Asia Pacific

    12.4. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Product

    12.5. Asia Pacific Newborn Screening Market Forecast, by Product

        12.5.1. Instruments 

            12.5.1.1. Tabletop

            12.5.1.2. Point-of-Care Testing 

        12.5.2. Assay Kits

    12.6. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type

    12.7. Asia Pacific Newborn Screening Market Forecast, by Test Type

        12.7.1. Dry Blood Spot Test

        12.7.2. Hearing Screen Test

        12.7.3. Critical Congenital Heart Disease (CCHD) Test

        12.7.4. X-ray or CT Scan

        12.7.5. Electrocardiogram (ECG) Test

        12.7.6. Others

    12.8. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by End-user

    12.9. Asia Pacific Newborn Screening Market Forecast, by End-user

        12.9.1. Hospitals

        12.9.2. Diagnostic Centers

        12.9.3. Maternity & Specialty Clinics

        12.9.4. Others

13. Latin America Newborn Screening Market Analysis

    13.1. Latin America Newborn Screening Market Overview

    13.2. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Latin America Newborn Screening Market Forecast, by Country/Sub-region

        13.3.1. Brazil

        13.3.2. Mexico

        13.3.3. Rest of Latin America

    13.4. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Product

    13.5. Latin America Newborn Screening Market Forecast, by Product

        13.5.1. Instruments 

            13.5.1.1. Tabletop

            13.5.1.2. Point-of-Care Testing 

        13.5.2. Assay Kits

    13.6. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type

    13.7. Latin America Newborn Screening Market Forecast, by Test Type

        13.7.1. Dry Blood Spot Test

        13.7.2. Hearing Screen Test

        13.7.3. Critical Congenital Heart Disease (CCHD) Test

        13.7.4. X-ray or CT Scan

        13.7.5. Electrocardiogram (ECG) Test

        13.7.6. Others

    13.8. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user

    13.9. Latin America Newborn Screening Market Forecast, by End-user

        13.9.1. Hospitals

        13.9.2. Diagnostic Centers

        13.9.3. Maternity & Specialty Clinics

        13.9.4. Others

14. Middle East & Africa Newborn Screening Market Analysis

    14.1. Middle East & Africa Newborn Screening Market Overview

    14.2. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Middle East & Africa Newborn Screening Market Forecast, by Country/Sub-region

        14.3.1. GCC Countries

        14.3.2. South Africa

        14.3.3. Rest of Middle East & Africa

    14.4. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Product

    14.5. Middle East & Africa Newborn Screening Market Forecast, by Product

        14.5.1. Instruments 

        14.5.2. Tabletop

        14.5.3. Point-of-Care Testing 

        14.5.4. Assay Kits

    14.6. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type

    14.7. Middle East & Africa Newborn Screening Market Forecast, by Test Type

        14.7.1. Dry Blood Spot Test

        14.7.2. Hearing Screen Test

        14.7.3. Critical Congenital Heart Disease (CCHD) Test

        14.7.4. X-ray or CT Scan

        14.7.5. Electrocardiogram (ECG) Test

        14.7.6. Others

    14.8. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by End-user

    14.9. Middle East & Africa Newborn Screening Market Forecast, by End-user

        14.9.1. Hospitals

        14.9.2. Diagnostic Centers

        14.9.3. Maternity & Specialty Clinics

        14.9.4. Others

15. Competition Landscape

    15.1. Competition Matrix 

    15.2. Company Share Analysis, 2019

    15.3. Company Profiles

        15.3.1. PerkinElmer, Inc. 

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Financial Overview

            15.3.1.3. Product Portfolio

            15.3.1.4. SWOT Analysis

            15.3.1.5. Strategic Overview

        15.3.2. Trivitron Healthcare 

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Strategic Overview

        15.3.3. Natus Medical Incorporated 

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Financial Overview

            15.3.3.3. Product Portfolio

            15.3.3.4. SWOT Analysis

            15.3.3.5. Strategic Overview

        15.3.4. Medtronic plc

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Financial Overview

            15.3.4.3. Product Portfolio

            15.3.4.4. SWOT Analysis

            15.3.4.5. Strategic Overview

        15.3.5. Thermo Fisher Scientific, Inc.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Financial Overview

            15.3.5.3. Product Portfolio

            15.3.5.4. SWOT Analysis

            15.3.5.5. Strategic Overview

        15.3.6. Bio-Rad Laboratories, Inc.

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Financial Overview

            15.3.6.3. Product Portfolio

            15.3.6.4. SWOT Analysis

            15.3.6.5. Strategic Overview

        15.3.7. GE Healthcare (General Electric Company)

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Financial Overview

            15.3.7.3. Product Portfolio

            15.3.7.4. SWOT Analysis

            15.3.7.5. Strategic Overview

        15.3.8. ZenTech S.A. 

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Strategic Overview

        15.3.9. MP BIOMEDICALS

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Strategic Overview

        15.3.10. Baebies, Inc. 

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Strategic Overview

        15.3.11. Masimo

            15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.11.2. Financial Overview

            15.3.11.3. Product Portfolio

            15.3.11.4. SWOT Analysis

            15.3.11.5. Strategic Overview

List of Tables

Table 01: Global Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 03: Global Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 04: Global Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 05: Global Newborn Screening Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America Newborn Screening Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: North America Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 08: North America Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 09: North America Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 10: North America Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: Europe Newborn Screening Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 13: Europe Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 14: Europe Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 15: Europe Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific Newborn Screening Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Asia Pacific Newborn Screening Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 18: Asia Pacific Newborn Screening Market Size (US$ Mn) Forecast, by Instruments, 2017–2031

Table 19: Asia Pacific Newborn Screening Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 20: Asia Pacific Newborn Screening Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 23: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 24: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 25: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 26: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 27: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 28: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 29: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 30: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Newborn Screening Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Newborn Screening Market Value Share, by Product, 2019

Figure 03: Global Newborn Screening Market Value Share, by End-user, 2019

Figure 04: Global Newborn Screening Market Value Share, by Test Type, 2019

Figure 05: Global Newborn Screening Market Value Share, by Region, 2019

Figure 06: Global Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031

Figure 07: Global Newborn Screening Market Revenue (US$ Mn), by Instruments, 2017–2031

Figure 08: Global Newborn Screening Market Revenue (US$ Mn), by Assay Kits, 2017–2031

Figure 09: Global Newborn Screening Market Attractiveness Analysis, by Product, 2021–2031

Figure 10: Global Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031

Figure 11: Global Newborn Screening Market Revenue (US$ Mn), by Dry Blood Spot Test, 2017–2031

Figure 12: Global Newborn Screening Market Revenue (US$ Mn), by Hearing Screen Test, 2017–2031

Figure 13: Global Newborn Screening Market Revenue (US$ Mn), by Critical Congenital Heart Disease (CCHD) Test, 2017–2031

Figure 14: Global Newborn Screening Market Revenue (US$ Mn), by X-ray or CT Scan, 2017–2031

Figure 15: Global Newborn Screening Market Revenue (US$ Mn), by Electrocardiogram (ECG) Test, 2017–2031

Figure 16: Global Newborn Screening Market Revenue (US$ Mn), by Others, 2017–2031

Figure 17: Global Newborn Screening Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 18: Global Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031

Figure 19: Global Newborn Screening Market Revenue (US$ Mn), by Hospitals, 2017–2031

Figure 20: Global Newborn Screening Market Revenue (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 21: Global Newborn Screening Market Revenue (US$ Mn), by Maternity & Specialty Clinics, 2017–2031

Figure 22: Global Newborn Screening Market Revenue (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 23: Global Newborn Screening Market Attractiveness Analysis, by End-user, 2021–2031

Figure 24: Global Newborn Screening Market Value Share Analysis, by Region, 2019 and 2031

Figure 25: Global Newborn Screening Market Analysis, by Region

Figure 26: North America Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 27: North America Newborn Screening Market Value Share (%), by Country, 2019 and 2031

Figure 28: North America Newborn Screening Market Attractiveness, by Country, 2021–2031

Figure 29: North America Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031

Figure 30: North America Newborn Screening Market Attractiveness, by Product, 2021–2031

Figure 31: North America Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031

Figure 32: North America Newborn Screening Market Attractiveness, by Test Type, 2021–2031

Figure 33: North America Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031

Figure 34: North America Newborn Screening Market Attractiveness, by End-user, 2021–2031

Figure 35: Europe Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 36: Europe Newborn Screening Market Value Share (%), by Country/Sub-region, 2019 and 2031

Figure 37: Europe Newborn Screening Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 38: Europe Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031

Figure 39: Europe Newborn Screening Market Attractiveness, by Product, 2021–2031

Figure 40: Europe Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031

Figure 41: Europe Newborn Screening Market Attractiveness, by Test Type, 2021–2031

Figure 42: Europe Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031

Figure 43: Europe Newborn Screening Market Attractiveness, by End-user, 2021–2031

Figure 44: Asia Pacific Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 45: Asia Pacific Newborn Screening Market Value Share (%), by Country/Sub-region, 2019 and 2031

Figure 46: Asia Pacific Newborn Screening Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 47: Asia Pacific Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031

Figure 48: Asia Pacific Newborn Screening Market Attractiveness, by Product, 2021–2031

Figure 49: Asia Pacific Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031

Figure 50: Asia Pacific Newborn Screening Market Attractiveness, by Test Type, 2021–2031

Figure 51: Asia Pacific Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031

Figure 52: Asia Pacific Newborn Screening Market Attractiveness, by End-user, 2021–2031

Figure 53: Latin America Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 54: Latin America Newborn Screening Market Value Share (%), by Country/Sub-region, 2019 and 2031

Figure 55: Latin America Newborn Screening Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 56: Latin America Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031

Figure 57: Latin America Newborn Screening Market Attractiveness, by Product, 2021–2031

Figure 58: Latin America Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031

Figure 59: Latin America Newborn Screening Market Attractiveness, by Test Type, 2021–2031

Figure 60: Latin America Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031

Figure 61: Latin America Newborn Screening Market Attractiveness, by End-user, 2021–2031

Figure 62: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 63: Middle East & Africa Newborn Screening Market Value Share (%), by Country/Sub-region, 2019 and 2031

Figure 64: Middle East & Africa Newborn Screening Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 65: Middle East & Africa Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031

Figure 66: Middle East & Africa Newborn Screening Market Attractiveness, by Product, 2021–2031

Figure 67: Middle East & Africa Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031

Figure 68: Middle East & Africa Newborn Screening Market Attractiveness, by Test Type, 2021–2031

Figure 69: Middle East & Africa Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031

Figure 70: Middle East & Africa Newborn Screening Market Attractiveness, by End-user, 2021–2031

Figure 71: Global Newborn Screening Market Share, by Company, 2019

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Newborn Screening Market